Cantor Fitzgerald, L. P. Foghorn Therapeutics Inc. Transaction History
Cantor Fitzgerald, L. P.
- $90.6 Billion
- Q2 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 150,000 shares of FHTX stock, worth $730,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$730,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FHTX
# of Institutions
82Shares Held
37MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$61.7 Million23.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$25.8 Million0.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$15.9 Million0.35% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.37MShares$11.5 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$11.2 Million0.01% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $203M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...